How Peer Reviewed Research Distinguishes Protandim from Other Products

How Peer Reviewed Research Distinguishes Protandim from Other Products

In this speech given in San Diego, California, October 2010, Dr. Joe McCord suggests we stay tuned to LifeVantage because Protandim is much different from other products sold similarly through Network Marketing.  Unlike such products as TupperWare, Protandim is a very complicated product.  Its value is not self-evident at the beginning.  “Five years ago, my view of what Protandim is, what it does, was very different from my view today.  In fact, my view today is very different from my view last week.”

Dr. McCord explains the peer review process.  When a manuscript is written and submitted to a journal  for possible publication, the journal editor selects several academic scientists who are well qualified to judge the quality of the work and the soundness of the conclusions drawn.  Usually they are leaders or at least well known contributors to the field.  They act as anonymous reviewers of the work.  They are free to question anything and everything about the work.  They are free to ask for additional experimentation to be performed, and that frequently happens.  They are free to question your statistical analysis, and to make criticism of the work.  The reviewers see each other’s  critiques, also anonymously. This is scrutiny of the highest degree.

The author must then respond to the critiques from each of the reviewers until all their concerns are satisfied.  It can go back and forth between the authors and the reviewers.  The process frequently takes 4 to 6 months or even longer.The reviewers are anonymous to each other, as well as to the authors, but they do get to see each other’s comments.  Often what one reviewer says in the first round will be picked up by another reviewer in the second round.  This goes back and forth until all the questions are settled, and everyone agrees the work is a sound well-done study.

In some journals only 5 to 10% of the papers submitted are ultimately accepted and published.  This is how rigorous the process is, and why peer-reviewed articles are more reliable, more informative, and more dependable than something you might google from the Internet, or find on some blog or company website  that could be published by anyone with absolutely no review whatsoever.

Dr. McCord noted that one of the most powerful tools and most informative resource is pubmed.gov, a website of the National Institutes of Health.  This is a database of peer-reviewed published biomedical literature across the planet, and maintained by the US National Library of Medicine.

A peer-reviewed article related to one of the active ingredients of Protandim is mentioned as it relates to cancer and Nrf2 activators.  While there had previously been some controversy as to whether antioxidant therapy was a good or bad thing in treating cancer, Dr. McCord  announced that recent research has shown that this actually sensitizes cancerous tumors to radiation and chemotherapy, making the cancers more readily treatable.

Dr. McCord explained that this study shows that, “Imposing a Nrf2 activator changes the way that tumors and normal tissues respond to radiation, and it does it in the best possible way.  It makes the radiation more effective at eliminating the tumor, and less effective at causing damage to the rest of your body.”  He makes the point that such developments continue to occur from day to day.  “We are in the middle of a rapidly changing field, and we need to stay tuned to this company and to sites like pubmed.gov, to get the latest information.”